Medical protein fiber for preventing and treating proliferation of mammal gland and its preparation method and application

A protein fiber and mammary gland hyperplasia technology, applied in the field of medicinal fibers, can solve problems such as strong odor, and achieve the effects of simple production process, abundant raw material sources, and easy realization.

Active Publication Date: 2008-12-31
义乌立芙纺织有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] The purpose of the present invention is to: provide a kind of medicinal protein fiber, to overcome the defect that the existing medicinal fabric has a big smell

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The first step is to prepare spinning dope. First prepare the spinning dope containing protein and high molecular polymer according to the existing technology, wherein the dry solid content A of protein is 50 parts by weight, and the dry solid content B of high molecular polymer is 49 parts by weight. Then the medicine for preventing and treating mammary gland hyperplasia and the drug transdermal absorption accelerator are added in the spinning stock solution and stirred evenly. The solid content D is 0.5 parts by weight;

[0030] In the second step, the spinning stock solution containing the anti-mammary gland hyperplasia drug and the transdermal absorption accelerator of the drug is made into a medicinal protein fiber, and the wet spinning process, the dry spinning process or the dry spray wet spinning process can be used to produce The finished medicinal protein fiber contains not only protein, but also drugs for preventing and treating mammary gland hyperplasia and...

Embodiment 2

[0039] In this embodiment, the dry solid content A of the protein in the spinning dope is 80 parts by weight, the dry solid content B of the high molecular polymer is 15 parts by weight, the dry solid content C of the drug for preventing and treating mammary gland hyperplasia is 4 parts by weight, and the drug penetrates The dry solid content D of the skin absorption accelerator is 1 part by weight, and other methods are the same as in Example 1.

Embodiment 3

[0041] In this embodiment, the dry solid content A of the protein in the spinning dope is 30 parts by weight, the dry solid content B of the polymer is 60 parts by weight, the dry solid content C of the drug for preventing and treating mammary gland hyperplasia is 8 parts by weight, and the drug penetrates The dry solid content D of the skin absorption accelerator is 2 parts by weight, and other methods are the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

This invention involves one kind of medicinal purposes protein textile fiber which is used for preventing and curing hyperplasia of mammary glands, and the process and application. The compound according to textile fiber gross is as follows: percentage A is protein, percentage B is high polymer, percentage C is medicine, percentage D is medicine that passes the skin absorption promoter, and the percentage is: 1<=A<=80,1<=B<=80,0<C <=20,0<D<=10. Among them, the high polymer is a kind of or a combination of polyvinyl alcohol, polyacrylonitrile, cellulose, polyvinyl acetate; the medicine can be one or a combination of xifen, isoflavone, bromocriptine and danazol; the medicine skin penetration enhancer can also be one or a combination of nitrogen alkone, oleic acid, N- methyl - 2- pyrrolidone, trimethylene glycol, or borneol.

Description

technical field [0001] The invention relates to a medicinal fiber, especially a medicinal protein fiber for preventing hyperplasia of mammary glands, its manufacturing method and application. Background technique [0002] Mammary gland hyperplasia is the most common breast disease, and its incidence rate accounts for the first place in breast diseases. For the treatment of mammary gland hyperplasia, traditional Chinese medicine generally takes orally or externally applies some traditional Chinese medicines that soothe the liver, regulate qi, activate blood and remove blood stasis; Western medicine uses hormone drugs or surgical treatment. The effect of traditional Chinese medicine treatment of this disease is better, but the oral treatment of traditional Chinese medicine is loaded down with trivial details because of boiling medicine, and the medication time is long, and the patient is difficult to adhere to, and the curative effect of western medicine treatment of this dise...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): D01F8/02D01F8/10D01F1/10A61K47/42A61K31/138A61K31/4985A61P15/14
Inventor 朱利民克雷斯·布兰福特-怀特樊在霞
Owner 义乌立芙纺织有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap